ADC Therapeutics Releases Preliminary Revenue Estimates for 2025 and Clinical Updates Discover ADC Therapeutics' preliminary performance metrics for 2025, including significant developments and future clinical trials related to ZYNLONTA.

ADC Therapeutics Releases Preliminary Revenue Estimates for 2025 and Clinical Updates #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #LOTIS_trials

ADC Therapeutics Provides Financial and Operational Insights for Q3 2025 ADC Therapeutics has released its financial results for Q3 2025, showcasing progress in clinical trials and increased funding in operations.

ADC Therapeutics Provides Financial and Operational Insights for Q3 2025 #Switzerland #ADC_Therapeutics #ZYNLONTA #Lausanne #LOTIS_trials